The board of Himalya International having accomplished USFDA approval for imports of OTC & Neutraceutical products has approved the launch of 12 products identified by US marketing team in first phase. New brand name be identified that will suit the basket of products planned for launch.
The board has also directed to meet the deadlines on launch of all new products and it was decided to hire more professionals in its Marketing & logistic team.
This was approved at the board meeting held on 30 October 2009.